Adenomyosis: The Overlooked Cause of Heavy, Painful Periods

What Is Adenomyosis?

Adenomyosis is a condition in which the endometrial tissue — the tissue that normally lines the inside of the uterus and sheds each month during menstruation — grows into the muscular wall of the uterus itself, known as the myometrium. With each menstrual cycle, this misplaced tissue responds to hormonal signals just as normal endometrium does: it thickens, breaks down, and bleeds. But because it is embedded within muscle rather than lining a cavity from which blood can exit, the blood and tissue have nowhere to go. The result is a uterus that becomes enlarged, boggy, and inflamed, with bleeding that is heavier and pain that is often intense.

Adenomyosis can be focal — confined to one area of the uterine wall — or diffuse, meaning the ectopic tissue is spread throughout the myometrium. Diffuse adenomyosis typically causes more severe and widespread symptoms. The condition is most commonly diagnosed in women in their 40s and early 50s, though it is increasingly being recognised in younger women including those who have never given birth — a cohort that was once thought to be largely unaffected.

Estimates of prevalence vary widely because adenomyosis has historically been difficult to diagnose without a hysterectomy. More recent studies using high-resolution transvaginal ultrasound and MRI suggest it affects somewhere between 20–35% of women — making it far more common than the relative silence around it would suggest.

How It Differs from Endometriosis

Adenomyosis and endometriosis are frequently confused — understandably so, since both involve endometrial-like tissue growing where it shouldn't. But they are distinct conditions with different locations, mechanisms, and management strategies, even though they often co-exist.

In endometriosis, endometrial-like tissue is found outside the uterus entirely — on the ovaries, fallopian tubes, bladder, bowel, peritoneum, and in severe cases, beyond the pelvis. In adenomyosis, the misplaced tissue remains within the uterus but has invaded the muscle wall. Think of it this way: endometriosis is an external condition, adenomyosis is an internal one.

The two conditions share many symptoms — heavy bleeding, painful periods, pelvic pain — but adenomyosis tends to produce more pronounced uterine enlargement and heavier bleeding, while endometriosis more commonly causes pain with bowel movements, urination, and sex related to external lesion location. Women with one condition have a significantly elevated risk of having both, so investigating for co-existing pathology is important.

Symptoms

The symptom profile of adenomyosis can range from silent to severely debilitating. Some women — particularly those with focal adenomyosis — have minimal symptoms and are diagnosed incidentally. Others are managing a set of symptoms that profoundly disrupt daily life, often for years before a correct diagnosis is reached.

The hallmark symptoms include:

• Heavy menstrual bleeding (menorrhagia), often with large clots and flooding that soaks through protection quickly
• Severe, cramping menstrual pain (dysmenorrhoea) that may begin before the period and persist throughout it
• A feeling of pressure, heaviness, or a dragging sensation in the pelvis
• An enlarged, tender uterus — sometimes described as feeling "boggy" on pelvic examination
• Chronic pelvic pain outside of menstruation
• Pain during sex (dyspareunia), particularly with deep penetration
• Spotting or light bleeding between periods
• Iron deficiency anaemia as a consequence of chronic heavy blood loss
• In some cases, subfertility or recurrent pregnancy loss

Why It's So Often Missed

Adenomyosis carries one of the longest diagnostic delay records of any common gynaecological condition. Women often spend six to ten years — sometimes longer — describing debilitating symptoms before receiving a correct diagnosis. Several factors contribute to this.

First, the gold standard for definitive diagnosis has historically been histological examination of uterine tissue following hysterectomy. This obviously creates an enormous diagnostic barrier for women who are still menstruating and have not yet reached the point of surgical intervention. However, technological advances in imaging have changed this significantly: experienced practitioners using high-resolution transvaginal ultrasound (TVUS) or MRI can now diagnose adenomyosis with good accuracy non-invasively.

Second, and more frustratingly, heavy and painful periods are still widely normalised in medicine. Women are regularly told that severe period pain is "just how it is for some women" — a dismissal that delays investigation and treatment. Painful, heavy periods are not normal. They are common, yes — but common and normal are not synonyms.

What Drives It

The exact mechanisms by which adenomyosis develops are not fully understood, but research points to several key contributors.

Oestrogen is central to its progression. Adenomyotic tissue — like normal endometrium — is oestrogen-sensitive and proliferates under oestrogen stimulation. Conditions of oestrogen excess or oestrogen dominance therefore tend to worsen adenomyosis, and the condition generally improves after menopause when oestrogen levels decline. This hormonal dependency is why many treatment approaches focus on suppressing oestrogen-driven signalling.

Inflammation plays a significant co-driving role. Adenomyotic lesions within the uterine wall trigger a local inflammatory response that impairs normal uterine muscle function and amplifies pain signalling. Prostaglandins — inflammatory compounds that drive uterine contractions during menstruation — are produced in excess in adenomyosis, which helps explain both the severity of cramping and the heavy bleeding.

Mechanical disruption to the endometrial-myometrial junction (the boundary layer between the lining and the muscle) is also implicated. Uterine trauma — from prior surgeries, caesarean sections, uterine instrumentation, or procedures like dilation and curettage — may allow endometrial cells to invade the muscle layer. This explains the historical association with prior pregnancies and uterine procedures, though again, adenomyosis is now well-documented in women with no such history.

Genetic predisposition is likely involved, and there is emerging research suggesting that early-life oestrogen exposure and epigenetic factors may play a role in susceptibility.

Managing Adenomyosis

Because adenomyosis is a chronic, oestrogen-dependent inflammatory condition, management works best when it addresses both the hormonal environment and the inflammatory load. While some women will ultimately need medical or surgical intervention, there are meaningful lifestyle and nutritional strategies that can reduce symptom severity.

• Adopt an anti-inflammatory diet: prioritise oily fish (rich in omega-3 fatty acids, which modulate prostaglandin production), colourful vegetables, legumes, nuts, and seeds while reducing red meat, refined carbohydrates, and ultra-processed foods
• Support oestrogen clearance through the liver and gut — cruciferous vegetables daily, adequate fibre, and minimal alcohol are the foundational trio
• Reduce exposure to xenoestrogens from plastics, synthetic fragrances, and conventional personal care products
• Prioritise magnesium, which reduces prostaglandin production, relaxes uterine muscle, and mitigates menstrual cramping — magnesium glycinate or bisglycinate is well tolerated and well absorbed
• Ensure adequate vitamin D, which has anti-inflammatory and anti-proliferative properties relevant to endometrial tissue
• Consider omega-3 supplementation (EPA and DHA from a quality fish oil) to counterbalance the pro-inflammatory prostaglandin environment
• Manage chronic stress — elevated cortisol impairs progesterone signalling and promotes systemic inflammation, both of which worsen adenomyosis
• Use a TENS unit or heat therapy during menstruation for localised pain relief as a complement to other interventions

Working With Your Doctor

Medical management of adenomyosis spans a wide range depending on symptoms, fertility goals, and disease severity. Hormonal treatments including the levonorgestrel-releasing IUD (Mirena), progestins, GnRH agonists, or combined hormonal contraceptives can reduce bleeding and pain — though they do not eliminate the underlying adenomyosis and symptoms typically return if treatment stops.

Uterine artery embolisation (UAE) and high-intensity focused ultrasound (HIFU) are minimally invasive procedural options that some women pursue when hormonal management is insufficient. Hysterectomy — removal of the uterus — remains the only definitive cure for adenomyosis, and for some women with severe, refractory disease, it is the right choice. But it should always be reached after an informed conversation about all available options and your own priorities.

If you suspect adenomyosis, request a transvaginal ultrasound with a practitioner who has experience in identifying adenomyosis features — not all sonographers are equally trained in this. If the ultrasound is inconclusive, an MRI can provide additional diagnostic clarity. Advocate clearly for yourself: describe the impact of your symptoms in concrete terms, including time off work, disrupted sleep, and quality-of-life effects. You deserve to be heard — and you deserve a diagnosis.

This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis and treatment of any health condition.